Very bullish. Lows are in. Nice timing by Floyd. GLTAL's
just listened to presentation. Q&A cut off so no Q&A for online listeners. nothing new, Murray is not a good presenter, you are correct. thanks for the feedback.
You should care about RA. They are the best biotech investor over the last decade. They were loading up on ACHN in the 2's last year. Owned something like 23 million shares of ACHN at one point. You should ignore the bashers on the board-- they're worthless.
WRONG dsc. Wilson bought 1,000,000 shares on the open market-- 355,683 at 1.04 on 5/28 and 644,317 at 1.03 on 5/29. OPEN MARKET DIRECT purchase. He was buying when I was-- NICE!!
God you're dumb. OF COURSE the data will determine the outcome of ACHN and the deal. The analogy that I presented is completely and unambiguously valid. Just like PCYC-- investors were expecting a buyout-- and when that didn't happen, both stocks dropped exactly 15% the day after their respective Janssen deals were announced. A lot of posters here think that ACHN must be a short-- because-- why didn't JNJ or some other company just buy them out? MY POINT is that their compounds/assets are potentially worth many MULTIPLES of what the market and JNJ are paying for today-- just like with PCYC. And like PCYC-- ACHN could double from these levels in the next 3 months. And several analysts say just that-- that JNJ could emerge (with ACHN) with the only regimen better than GILD's. Shorts are going to get severely burned.
Google the press release from Dec. 8, 2011. PCYC traded down 23% from the peak 3 days before the deal was announced, to the day after the deal was announced (Dec. 5th peak 15.82 to 12.16 low Dec.9th)-- and also dropped 15% the day after the deal was announced, on Dec. 9th. 12.16 marked the low in PCYC-- it doubled in 3 months post the Janssen deal and the rest is history. PCYC gets bought out at $260.
ALMOST identical to ACHN/Janssen deal. ACHN peaked the day before the deal was announced, and dropped 15% the day after the deal was announced. There is no reason why the 8.96 low on May 20th should not mark the low in the stock. Could we get a double in the next 3 months?? Not out of the realm of possibility.
The only technical difference is that PCYC was above its 200-day moving avg. and ACHN is now below its 200-day. From a purely technical perspective, ACHN does not look as good as PCYC in Dec. 2011.
No matter what the deal with JNJ is. There is no poison pill. Any company can come in and offer whatever they want-- and ACHN's board has a fiduciary duty to consider all offers. Speculators are selling simply because they didn't get a deal today. The bidding has JUST STARTED. HELLO.
wow you guys are newbies. ANYONE can come in and offer whatever $20, $30, etc. ACHN has a DUTY to shareholders to consider the offer and the board to decide. If they turn down a good offer, shareholders would likely sue. They are a public company.
No-- sometimes it's better to act after the bidding has started and not be the first to bite. Now that the bar is set sufficiently low-- GILD could offer $20 (not $30 or $40). And at least make a competitor (JNJ) pay more.